about
Thirty years of research on met receptor to move a biomarker from bench to bedsideAssociation of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signalingHepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathwayInteraction of calmodulin with the cytoplasmic domain of platelet glycoprotein VITensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells.Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis.Caspases shutdown nonsense-mediated mRNA decay during apoptosis.Necrosis- and apoptosis-related Met cleavages have divergent functional consequencesThe multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.Caspase Cleavages of the Lymphocyte-oriented Kinase Prevent Ezrin, Radixin, and Moesin Phosphorylation during Apoptosis.ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity.MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering.Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist.Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function.Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage.Premature termination codon readthrough in human cells occurs in novel cytoplasmic foci and requires UPF proteins.HGF/SF regulates expression of apoptotic genes in MCF-10A human mammary epithelial cells.Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin.A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI.The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells.Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity.Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor gamma-chain.Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases.Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors.Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection.Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung Carcinomas.High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form.The caspase-generated cleavage product of Ets-1 p51 and Ets-1 p27, Cp17, induces apoptosis.The multiple paths towards MET receptor addiction in cancer.[MET receptor inhibition: Hope against resistance to targeted therapies?]How does met regulate the survival/apoptosis balance?The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase.[Thirty years of Met receptor research: from the discovery of an oncogene to the development of targeted therapies].Tensin-4-Dependent MET Stabilization Is Essential for Survival and Proliferation in Carcinoma Cells.Expression of GD3 synthase modifies ganglioside profile and increases migration of MCF-7 breast cancer cellsRegulation of RAS in human platelets
P50
Q26828909-2BB4C852-3C0D-48AD-8BBB-7935470ED8CCQ28214216-C4B9C9AE-FE17-41A3-98A9-5F0FB11E534CQ28214429-AF08C8B1-D68B-4343-A6C3-B9CA95B40EDEQ28217508-46D319DB-28B9-4759-A521-93058304CA61Q33984904-CEA4C651-0424-44EA-AA70-690D2F5CF88EQ35865254-54915853-DBB8-4914-BFA1-B06450992008Q36288298-42253AA4-40EF-4006-A5F0-7311EDE10318Q36346969-04F8FFB6-DCC5-4E33-ADDC-82F59157CF2EQ36843122-C100BC02-C0C9-4443-BDD8-56F0F87E467BQ36876186-F9F4AB76-7033-4BDD-84D8-13A5F51AB14AQ37149914-BD268D0F-F323-4FCE-8A0E-BAA56AC1754AQ37472880-279E201A-3B08-475C-85BF-9F2E7898ABCCQ37706900-956D33AC-C7D2-4353-AE51-6961DC2DF2ACQ38674666-755CB356-15F6-4465-9C50-8D939775520AQ38735120-69143EBD-B47C-4BF4-AB33-9FE732E6D678Q38846778-000F9D2F-1B78-4569-9770-36F2380BFBDBQ39764895-F2C75CF6-0EB8-476E-BC22-25316D30A203Q39849915-58C2F25C-A146-435C-A89C-1AB7858BF6A3Q40119962-1ABBC678-ECC3-41A8-90E3-7A396B59E1F8Q40154441-50A706AC-6A22-4A1C-B191-3BA841AEF408Q40252186-D02AC741-6BC2-478A-86BA-9EF918EDF09EQ40724056-9D2C7BB6-5A46-407F-8D32-9F8FEE4FCDECQ40807170-539F71C7-9E12-4777-9BBF-02225851B4FCQ41107973-D3F0042F-DDDD-4C6C-A870-B6FE9ECD1BB1Q42911687-23DF13E6-A005-431E-A65E-525CB6309CC7Q44504083-8F4CCAF1-BE07-49EF-A89A-108554626886Q45423056-F05D3809-0000-4F3A-B2CF-2C42118EEA42Q47236718-F1D1C5E2-AE46-42C6-9A64-92914A2B3A5DQ50093685-E2C45154-CC69-4A7D-AD4E-CB3305E365FFQ51184551-2F6206D1-7BF7-4081-9900-003DB9F6E58EQ51355608-E8A2CF94-442E-4811-BFCB-3EEF3C8DC802Q51396839-60F2ABAB-D207-4805-9C82-36B04CE4C5DFQ52316580-0E564705-AEC2-4432-AD32-4520EC7CF411Q53760857-22AADE5F-38CC-40B8-B270-CA32C9C18292Q54389813-E4330CF5-FB37-43EE-8145-CF9DAF72AA4DQ54532386-BA078BF7-9B4A-4A7B-B8DB-93A2017D9297Q55070676-742B818A-C450-423A-8DE8-6BBF622DAD03Q55545524-81BDCBF7-BDFD-40E4-B871-33DC109FF560Q63362568-11BAE4C5-A45C-479C-8765-7BA272ECDF18Q63408034-44CCCBC9-2FC1-44E2-814C-894B8616702D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Tulasne
@ast
David Tulasne
@en
David Tulasne
@es
David Tulasne
@nl
David Tulasne
@sl
type
label
David Tulasne
@ast
David Tulasne
@en
David Tulasne
@es
David Tulasne
@nl
David Tulasne
@sl
prefLabel
David Tulasne
@ast
David Tulasne
@en
David Tulasne
@es
David Tulasne
@nl
David Tulasne
@sl
P106
P1153
6601987569
P21
P31
P496
0000-0002-6764-7242